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Research Article
Introduction
Cancer is infamous as the leading cause of death in the 
world. In the United States, breast cancer is the most com-
mon type of cancer for women.1 In addition, the majority of 
breast cancer deaths are mainly because of cancer metasta-
sis to other parts of the body.2 For years, research into a cure 
for cancer has been ongoing, and inhibition of the meta-
static cascade is one of the goals. The association of func-
tional foods, such as probiotics, with cancer therapy has 
become an emerging field of study. Although the use of pro-
biotics as a therapeutic agent is most common in colon-
related diseases3,4 because the bacteria can interact directly 
with the colon after consumption, probiotics also demon-
strate antitumor properties in breast cancer cells.5
Kefir was introduced more than a thousand years ago in 
the Caucasus Mountains in Central Asia. It is a traditional 
beverage made from the fermentation of kefir grains with 
milk or water.6 Kefir grains contain various kinds of micro-
bial flora, including the most commonly studied species 
with probiotic potential such as Lactobacillus acidophilus, 
Lactobacillus casei, and Lactococcus lactis subsp Lactis.7,8 
Because these species have numerous different strains, not 
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Abstract
Background. Kefir is a unique cultured product that contains beneficial probiotics. Kefir culture from other parts of the world 
exhibits numerous beneficial qualities such as anti-inflammatory, immunomodulation, and anticancer effects. Nevertheless, 
kefir cultures from different parts of the world exert different effects because of variation in culture conditions and media. 
Breast cancer is the leading cancer in women, and metastasis is the major cause of death associated with breast cancer. 
The antimetastatic and antiangiogenic effects of kefir water made from kefir grains cultured in Malaysia were studied in 4T1 
breast cancer cells. Methods. 4T1 cancer cells were treated with kefir water in vitro to assess its antimigration and anti-
invasion effects. BALB/c mice were injected with 4T1 cancer cells and treated orally with kefir water for 28 days. Results. 
Kefir water was cytotoxic toward 4T1 cells at IC
50
 (half-maximal inhibitory concentration) of 12.5 and 8.33 mg/mL for 48 
and 72 hours, respectively. A significant reduction in tumor size and weight (0.9132 ± 0.219 g) and a substantial increase 
in helper T cells (5-fold) and cytotoxic T cells (7-fold) were observed in the kefir water–treated group. Proinflammatory 
and proangiogenic markers were significantly reduced in the kefir water–treated group. Conclusions. Kefir water inhibited 
tumor proliferation in vitro and in vivo mainly through cancer cell apoptosis, immunomodulation by stimulating T helper 
cells and cytotoxic T cells, and anti-inflammatory, antimetastatic, and antiangiogenesis effects. This study brought out the 
potential of the probiotic beverage kefir water in cancer treatment.
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every single strain has the potential to be probiotic. This 
important characteristic makes kefir suitable as a probiotic 
beverage. Probiotics refer to live microorganisms, which 
when administered in adequate amounts, confer a health ben-
efit on the host.9 Kefir has been consumed extensively for 
years because it is believed to promote good health. This 
claim was verified by recent studies, which showed that kefir 
can aid in alleviating lactose intolerance,10 inflammation,11,12 
and high total cholesterol13,14 as well as exhibiting immuno-
modulation properties.15 It has also been reported that kefir 
has the ability to induce cytotoxicity and reduce cancer 
growth in vivo.5,16
Furthermore, studies by de Moreno de LeBlanc et al5,17 
on the administration of commercial milk kefir from Canada 
in a breast cancer murine model determined that it can slow 
down cancer by elevating local immune response and 
selected cytokines. Nevertheless, an in-depth study is 
needed on the antitumor and antimetastatic effects of kefir 
in a murine breast cancer model. Thus, this study focused 
on the antimetastatic effects of kefir water made from kefir 
grains grown in Malaysia on 4T1 cells in in vitro and in 
vivo murine models.
Material and Methods
Sample Preparation
Kefir grain was obtained from a local store in Kuala Lumpur 
(http://mykefirworld.com/); 200 mg of kefir grain was 
added into a glass vessel containing brown sugar (200 g) 
dissolved in 1.5 L of mineral water. The fermentation was 
performed for 24 hours at room temperature. After that, the 
grain was filtered out from the fermented medium, and the 
kefir water was freeze dried. Dried kefir water was diluted 
in phosphate-buffered saline (PBS; 500 mg/mL) and stored 
at 4°C until used.
Animal and Experimental Groups
Female BALB/c mice at the age of 5 to 6 weeks (20-22 g) 
were obtained from the Animal House of Univesiti Putra 
Malaysia, Serdang (UPM, Malaysia). The mice were sepa-
rated into 3 groups (n = 7 for each group): (1) normal group; 
(2) untreated tumor group, in which mice were fed orally 
with distilled water; and (3) kefir water–treated group, in 
which mice with tumor were fed orally with kefir water (150 
mg/kg body weight per day). Kefir dosage was determined 
based on previous studies.16,18,19 All mice in the tumor group 
were inoculated with 1 × 105 4T1 cells subcutaneously, and 
treatment was administered orally with samples on the same 
day of tumor inoculation for 28 days. The mice were main-
tained under standard animal house conditions, with a regu-
lar 12-hour dark-light cycle at 25°C. Water and standard diet 
pellet were provided ad libitum. All the experiments using 
animals were performed under the ethical guidelines set by 
Universiti Putra Malaysia for the care of lab animals (UPM/
IACUC/AUP-R042/2015).
TUNEL Assay
The terminal deoxynucleotidyl transferased UTP nick end-
labeling (TUNEL) DNA fragmentation assay was carried 
out according to the user’s guidelines in DeadEnd colori-
metric TUNEL assay protocol (Promega, USA). Briefly, 
tumor tissue sections from untreated and kefir water–treated 
groups on microscope slides were deparaffinized in xylene 
for 5 minutes. Then, the slides were immersed in sequential 
concentrations of ethanol (100%, 95%, 85%, 70%, and 
50%) and in 0.85% NaCl for 5 minutes. Next, the slides 
were immersed in PBS (pH 7.0) before they were fixed in 
4% paraformaldehyde for 15 minutes. The slides were 
washed with PBS, and the tissues were permeabilized with 
the provided proteinase K. The fixing steps were repeated 
before the tissues were equilibrated using an equilibrium 
buffer. Then, the tissue sections were labeled with terminal 
deoxynucleotidyl transferase and blocked in hydrogen per-
oxide. The slides were incubated in streptavidin-horserad-
ish peroxidase (HRP) and developed using 3, 
3’-Diaminobenzidine (DAB) substrate. Finally, the slides 
were mounted and viewed under bright field microscopy 
(Motic, Hong Kong), and the apoptotic cells were counted 
from 5 different fields in every tumor slide (n = 7 per group).
Hematoxylin and Eosin (H&E) Staining
The tumor tissues from untreated and kefir water–treated 
groups were fixed in 10% buffered formalin, embedded in 
paraffin, and sectioned. The sections were stained with 
hematoxylin and eosin and viewed under bright field 
microscopy (Motic, Hong Kong) for mitotic cell identifica-
tions. The mitotic cells were counted from 5 different fields 
in every tumor slide (n = 7 per group).
Nitric Oxide Assay
NO in tumor samples from untreated and kefir water–
treated groups was measured according to the user’s guide-
lines in the Griess reagent kit (Sigma, USA). Tumors were 
meshed using a plunger and a 70-µm cell strainer in PBS. 
The supernatants were collected and mixed with the pro-
vided Griess Reagent and deionized water. After the sample 
mixtures were incubated for 30 minutes, the absorbance 
was measured using a microplate reader (Bio-Tek 
Instruments, Winooska, VT) at 548 nm.
Malondialdehyde (MDA) Assay
The level of lipid peroxidation in tumor samples from 
untreated and kefir water–treated groups was measured 
using the MDA assay by thiobarbituric acid reaction, 
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according to Ohkawa et al.20 Tumors were meshed using a 
70-µm cell strainer in PBS. The supernatants were collected 
and mixed with butylated hydroxytoluene (Sigma, USA) 
and 2,4,6-trichloroanisole before they were vortexed and 
kept on ice for 2 hours. Afterward, the mixtures were centri-
fuged, and the supernatants were mixed with thiobarbituric 
acid and boiled for 15 minutes. The absorbance of the mix-
tures was measured at 532 nm using a spectrophotometer 
(Beckman Coulter, USA). Tetramethoxypropan (Sigma, 
USA) was used as standard.
Serum Cytokine Detection of Interleukin 2 (IL-
2), IL-1β, IL-10, and Interferon γ (IFN-γ)
Blood serum was collected from normal, untreated, and 
kefir water–treated groups and subjected to cytokine detec-
tion using a Duoset ELISA assay kit (R&D Systems, USA; 
catalog no: DY401, DY485, DY417, DY402) per the user’s 
guidelines. The assay plate was coated with capture anti-
body overnight. The plate was washed with PBS 0.5% 
Tween 20 and incubated with block buffer followed by 
serum samples for 2 hours. Next, the plate was washed 
again and incubated with detection antibody for 2 hours. 
Streptavidin-HRP was added to the plate for 20 minutes 
after the plate was washed. Then, the plate was incubated 
with substrate solution for 20 minutes and the reaction was 
ended with the addition of stop solution. The absorbance 
was measured using a microplate reader (Bio-Tek 
Instruments, Winooska, VT) at 450 nm.
Immunophenotyping
Immunophenotyping of spleen CD3, CD4, and CD8 were 
done based on Yeap et al.21 Briefly, the harvested spleens 
from normal, untreated, and kefir water–treated groups 
were meshed, and red blood cells were lysed using lysis 
buffer (8 g NH
4
Cl, 1 g Na
2
EDTA, 0.1 g KH
2
PO
4
 at pH 7.4). 
The cells were washed with PBS and stained with the CD3, 
CD4, and CD8 antibodies (Abcam, USA; Catalog No: 
ab11089, ab25475, ab22378) for 2 hours. The cells were 
then washed, fixed in 4% paraformaldehyde for a week, and 
run through a FACS-Calibur flow cytometry system (BD, 
USA).
Lung Clonogenic Assay
Clonogenic assay was performed to determine the number 
of metastatic 4T1 cells in the lung.22 The harvested lungs 
from untreated and kefir water–treated groups were washed 
with PBS, minced into small pieces, and subjected to diges-
tion in 2 mg/mL collagenase type IV for 1 hour in a 37°C 
water bath. The digested lungs were meshed and filtered 
through 70-µm strainers using syringe plungers. Then, the 
digested lungs were centrifuged at 2000 rpm for 5 minutes 
and washed twice with PBS. The cell pellets were resus-
pended in Roswell Park Memorial Institute medium (RPMI) 
containing 60-µm 6-thioguanine for clonogenic growth. 
The suspensions were serially diluted in 6-well plates. After 
10 days, the clonogenic cells were fixed in methanol and 
stained with 0.5% crystal violet. Clonogenic cells were 
counted for each group.
Bone Marrow Smearing
Femurs from untreated and kefir water–treated mice were 
harvested; the bone marrows were located and washed out 
with PBS. The bone marrow solution was dropped onto 
clean glass slides and smeared across the slide. After the 
slides dried, they were fixed in methanol for 30 minutes and 
stained with Giemsa for 2 hours. The slides were viewed 
under an inverted microscope (Nikon, Japan).
Quantitative Real-Time Polymerase Chain 
Reaction (qPCR)
Tumors from untreated and kefir water–treated groups were 
snap frozen with liquid nitrogen and ground using a mortar 
and pestle. Total RNA was extracted from the ground sam-
ples using the Qiagen RNEasy Mini Kit (Qiagen, Germany). 
The RNA (1 µg) obtained was converted into cDNA using 
Maxima First Strand cDNA synthesis kit (Thermo Scientific, 
USA) and loaded into a thermal cycler (Labnet, USA). The 
cDNA was subjected to real-time polymerase chain reaction 
using SYBR Select Master Mix (Life Technologies, USA) 
in Eco Illumina (Illumina, USA) to quantify gene expres-
sion of the selected genes described in Table 1. The primers 
were obtained from Primer-Blast NCBI (http://www.ncbi.
nlm.nih.gov/tools/primer-blast/) and Primer Bank (http://
pga.mgh.harvard.edu/primerbank/). GAPDH and ACTB 
were used as housekeeping genes. The expressions were 
analyzed using Eco Study (Illumina, USA).
Proteome Profiler Angiogenesis Antibody Array
The detection of multiple cytokines in protein samples was 
done using the Mouse Angiogenesis Antibody Array kit 
(Ray Biotech, USA). The proteins from tumors harvested 
from untreated and kefir water–treated groups were 
extracted from ground samples using QIAShredder (Qiagen, 
Germany) and RIPA-Protease Inhibitor buffer (50 mM Tris-
HCl pH 8.0, 150 mM NaCl, 1.0% TritonX-100, 0.5% 
sodium deoxycholate, 0.1% SDS, Protease inhibitor [Roche, 
USA]). Then, the protein samples were subjected to the pro-
tein array per the user’s guidelines. In brief, the provided 
glass chip was blocked using blocking buffer for 30 min-
utes, and samples were incubated in the chip overnight at 
4°C. After 24 hours, the chip was washed 3 times with 
selected wash buffer. The chip was then incubated with 
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biotin-conjugated anticytokine reagent for 2 hours and with 
streptavidin-fluor for 2 more hours. The chip was washed 
twice with selected wash buffer and distilled water. The 
chip was allowed to dry and scanned using the Axon Gene 
Pix 4000B (Molecular Devices, Sunnyvale, CA), and the 
values were extracted using the Axon Gene Pix Pro 6.1 
(Molecular Devices, Sunnyvale) software. The data were 
then analyzed based on calculations provided in the user’s 
guidelines.
Statistical Analysis
Unless stated otherwise, the results were expressed as the 
means and SDs of all mice for each group (n = 7 for each 
group). Statistical significance (P < 0.05) was determined 
using Student’s t-tests and performed using GraphPad 
Prism (version 6.0) against the untreated group.
Results
Kefir Water Induced Cell Cytotoxicity and 
Positively Suppressed Cell Migration and 
Invasion In Vitro
MTT assay was performed on 4T1 cells to evaluate the cyto-
toxicity of the kefir water at the highest dosage of 50 mg/mL. 
The half-maximal inhibitory concentration (IC
50
) values were 
determined and selected for further bioassays. The IC
50
 values 
after 48 hours and 72 hours were 12.5 and 8.33 mg/mL, 
respectively. The migration and invasion ability of 4T1 cells 
were challenged with the exposure to 3 concentrations of kefir 
water at 3.125, 6.25, and 12.5 mg/mL through a Matrigel 
membrane. The number of migrating cells was significantly 
decreased in the treatment groups as compared with the 
untreated group (supplementary data, available at http://ict.
sagepub.com/supplemental). The percentage of migrating 
cells was reduced by 88.03% ± 1.44% when treated with 12.5 
mg/mL kefir water. The same pattern can be observed in the 
invasion assay, where the invaded cells were reduced in num-
ber when exposed to higher concentration of kefir water, with 
72.83% ± 4.01% of cell invasion being suppressed at 12.5 mg/
mL. Hence, it can be concluded that the rate of 4T1 cell migra-
tion and invasion was dose dependent, whereby as the con-
centration of kefir water increased, the rate decreased. In the 
wound healing assay, a significant reduction in wound healing 
in comparison to untreated cells was observed at 3 concentra-
tions of kefir water (3.12, 6.25, and 12.5 mg/mL) at 12 and 24 
hours (supplementary data, available at http://ict.sagepub.
com/supplemental). The wound closures between the 3 con-
centrations were distinguishable only at 24 hours, where the 
percentages were 67.9%, 62.5%, and 39.6%, at the respective 
ascending concentrations.
Kefir Water Obstructed Ex Vivo Angiogenesis in 
Mouse Aortic Ring
Sections of mouse aortic rings were embedded in Matrigel and 
exposed to 12.5 mg/mL of kefir water for 10 days to allow ves-
sels to grow. The formation of microvessels sprouting from the 
aortas was observed and counted in every well. As compared 
Table 1. The Gene Name, Accession Number, and Sequence of Primers Used in Real-Time qPCR.
Gene Name Accession Number Sequence of Primers
MMP-9 NM_013599.3 F: 5’-GCCGACTTTTGTGGTCTTCC-3′
R: 5′-GGTACAAGTATGCCTCTGCCA-3′
IL-1β NM_008361.3 F: 5′-GCCACCTTTTGACAGTGATGAG-3′
R: 5′-GACAGCCCAGGTCAAAGGTT-3′
NF-κB NM_0086892 F: 5′-CCTGCTTCTGGAGGGTGATG-3′
R: 5′-GCCGCTATATGCAGAGGTGT-3′
iNOS NM_010927.3 F: 5′-GCACCGAGATTGGAGTTC-3′
R: 5′-GAGCACAGCCACATTGAT-3′
ICAM1 NM_010493.2 F: 5′-TGCTCAGGTATCCATCCATCC-3′
R: 5′-ACGGTGCCACAGTTCTCAA-3′
G-CSF NM_007782 F: 5′-TGCACCCTGACTGGAGTTAC -3′
R: 5′-TGAAATCTCGATGTGTCCACAG -3′
GM-CSF NM_009970 F: 5′-TGCTCTTCTCCACGCTACTG -3′
R: 5′-GGGGTCGAAGGTCAGGTTG-3′
TNF-α NM_013693 F: 5′-CCCTCACACTCAGATCATCTTCT -3′
R: 5′-GCTACGACGTGGGCTACAG-3′
IL-4 NM_021283 F: 5′-GGTCTCAACCCCCAGCTAGT-3′
R: 5′-GCCGATGATCTCTCTCAAGTGAT-3′
GAPDH NM_008084.3 F: 5′-GAAGGTGGTGAAGCAGGCATC-3′
R: 5′-GAAGGTGGAAGAGTGGGAGTT-3′
ACTB NM_007393.3 F: 5′-TTCCAGCCTTCCTTCTTG-3′
R: 5′-GGAGCCAGAGCAGTAATC-3′
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with the untreated aortas, the aortas in the kefir water–treated 
group produced minimal microvessel growth (supplementary 
data, available at http://ict.sagepub.com/supplemental).
Kefir Water Reduced 4T1 Tumor Growth in 
Mice
Figure 1A shows the image of tumor harvested from cancer 
mice after 28 days of treatment. Tumor size in kefir water–
treated mice was smaller than that in untreated mice. The 
tumor weight and volume were also reduced significantly 
by 29.53% and 32.92%, respectively, in kefir water–treated 
mice as compared with the untreated mice (Figure 1).
Kefir Water Inhibited Cell Mitosis and Enhanced 
Tumor Apoptosis in Mice
Tumor sections were paraffin embedded on glass slides and 
subjected to H&E staining and TUNEL assay. The histology 
analysis of untreated tumor sections displayed a greater 
number of differentiated cancer cells (Figure 2A). Black 
circles in Figure 2A indicate mitotic cells that underwent cell 
division. Apoptosis of cancer cells in tumor was observed in 
the TUNEL assay. A higher number of apoptotic cancer cells 
were observed in the kefir water–treated tumor section as 
compared with the untreated section (Figure 2B).
Kefir Water Decreased Metastasis to Lung and 
Bone Marrow
The antimetastatic effects of kefir water on tumor were fur-
ther analyzed in a clonogenic assay and bone marrow–
smearing assay. In the clonogenic assay, 6-thioguanine is a 
selective medium to grow 4T1 cells. The metastatic poten-
tial of 4T1 cells to the lung was observed after 10 days. The 
number of 4T1 cells metastasized in the lung of kefir water–
treated mice was significantly lower than in untreated mice, 
as shown in Figure 3A. In the bone marrow–smearing assay, 
metastatic cells were identified by the presence of large and 
abnormal cells. Based on Figure 3B, metastatic 4T1 cells 
were only observed in the untreated group.
Kefir Water–Controlled Cytokine Expressions in 
Serum
The expression levels of cytokines involved in angiogenesis 
and inflammation were measured using blood serum. The lev-
els of tumor pro-growth-related cytokines (IL-10 and IL-1β) 
Figure 1. Tumor size, weight (g) and volume (cm3), obtained from 4T1 cell-challenged mice. (A) Images of tumor harvested from 
untreated group and kefir water–treated group after 28 days. (B) Tumor weight of untreated group and kefir water–treated group 
after 28 days. (C) Tumor volume of untreated group and kefir water–treated group after 28 days. Each value represents the mean ± 
SD (n = 7 mice per group). Significant difference (*P < .05) from the untreated group was calculated using the t-test.
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were significantly decreased in the kefir water–treated group 
(Figure 4). On the other hand, the levels of immunomodulation 
related cytokines (IFN-γ and IL-2) were significantly 
increased in the kefir water–treated group (Figure 4).
Figure 2. Hematoxylin and eosin stain image of tumor from untreated group and kefir water–treated group. Black circles show 
mitotic cells. (A) The histogram shows the number of mitotic cells per tumor section in the untreated group and kefir water–treated 
group (n = 3 slides per mice). Significant difference (*P < .05) from the untreated group was calculated using the t-test. (B) Terminal 
deoxynucleotidyl transferased UTP nick-end labeling (TUNEL) assay image of the tumor from untreated and kefir water–treated 
groups. Black circles show DNA fragmentation and apoptotic cells (dark brown spots). The histogram shows the number of apoptotic 
cells per tumor section in the untreated group and kefir water–treated group (n = 3 slides per mice). Significant difference (*P < .05) 
from the untreated group was calculated using the t-test.
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Kefir Water Enhanced Immune Response in Spleen
The population of selected immune markers (T-helper CD4+/
CD3+) and cytotoxic T cells (CD8+/CD3+) was calculated 
based on immunophenotyping by flow cytometry. As shown 
in Figure 5, the population of T-helper CD4 cells in the kefir 
water–treated group as compared with the untreated group 
was significantly higher, by 5-fold. The same pattern was 
observed in the population of cytotoxic CD8 T cells, where it 
was increased by 7-fold. In addition, the population of the 
immune cells between the normal group and the kefir water–
treated group showed no statistical difference.
Kefir Water Decreased Lipid Peroxidation and 
NO Levels in Tumor
The levels of lipid peroxidation of MDA and NO in tumor 
supernatant were determined, and reductions were seen in both 
assays (Figure 6). Kefir water had decreased the levels of both 
inflammation-related chemicals in the tumors by about 3-fold.
Kefir Water Reduced the Expression of 
Inflammation and Metastatic-Related Genes and 
Proteins In Vivo
The mRNA expressions of ICAM, iNOS, MMP-9, IL-1β, 
NF-κB, G-CSF, GM-CSF, IL-4, and TNF-α genes were 
downregulated in the kefir water–treated group as com-
pared with the untreated group (Figure 7A). A significant 
downregulation of iNOS and IL-1β by 3-fold were observed 
in the kefir water–treated group. In the angiogenesis pro-
teome profiler assay, the levels of selected proangiogenesis 
proteins were downregulated and that of antiangiogenesis 
proteins were upregulated in the kefir water–treated group 
(Figure 7B).
Discussion
Extensive research has been done to tackle breast cancer pro-
gression, but complete understanding is still a long way off. 
Diet is one of the factors that leads to cancer development, 
Figure 3. (A) The images of clonogenic colonies in lung harvested from 4T1 cell–challenged mice at a dilution factor of 104 and the 
number of 4T1 colonies formed after 10 days of incubation (n = 6 mice per group). Significant difference (*P < .05) from the untreated 
group was determined using the t-test. (B) Bone marrow smear for untreated and kefir water–treated group at 200× and 400× 
magnification.
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and the association between diet and cancer is currently being 
investigated. Scientists have found that the occurrence of 
tumors in animals can be manipulated by their diet intake.23 
A study on milk kefir provides an insight into its antiprolif-
erative effects on breast cancer cells in vitro.24 Although kefir 
has been commercialized in some places in the world, the 
mechanism of action behind the anticancer claim of kefir, 
especially kefir water, is still underresearched. Therefore, this 
study was carried out to further investigate the anti-metasta-
sis and antiangiogenesis potential of kefir from Malaysia in 
triple negative 4T1 murine breast cancer cells. Triple nega-
tive breast cancer (TNBC) is known to have poor prognosis 
and highly metastasis compared to other breast cancer types. 
Women with TNBC developed a significantly higher visceral 
metastasis as the first site of distant recurrence than women 
with other breast cancer types.25 Other than that, the develop-
ment of brain metastases is higher in the triple-negative phe-
notype compared with other types of breast cancer.26
Kefir water showed cytotoxicity toward 4T1 cells in the 
MTT assay, and the IC
50
 obtained was used in subsequent in 
vitro migration assays. The significant reduction in cell 
migration and invasion in kefir water–treated cells in vitro 
demonstrated the potency of kefir water as an antimetasta-
sis agent. Angiogenesis is the formation of new blood ves-
sels from existing vessels, and it has an important role in 
wound healing and development of tumors.27 This feature is 
stimulated by proangiogenic factors, which are essential for 
tumor metastasis.28 The ability of kefir water to inhibit 
angiogenesis was shown in the ex vivo mouse aortic ring 
assay, where lower microvessel growth was significantly 
observed in treated aortas (supplementary data, available at 
http://ict.sagepub.com/supplemental).
The effectiveness of kefir water in the inhibition of 
breast cancer metastasis was further tested in an in vivo 
model using BALB/c mice. After 28 days of treatment, the 
size and weight of tumors in the kefir water–treated mice 
were reduced significantly. Normal cell growth and prolif-
eration are regulated within the cell cycle. Cancer cells 
divide rapidly because they deregulate the cell cycle signal 
and, thus, proliferate at their own pace.28 Dividing cells in 
tumor sections were analyzed using H&E staining, and as 
can be seen in Figure 2A, the number of dividing cells was 
reduced in the kefir water–treated tumor section. TUNEL 
assay was performed on tumor tissue sections to detect 
DNA damage. An increase in DNA fragmentation was 
observed in kefir water–treated tumor sections in the 
TUNEL assay. DNA fragmentation is one of the indicators 
for cell apoptosis.29 Therefore, the increase in DNA frag-
mentation indicated that the tumor cells were undergoing 
apoptosis.
The correlation between inflammation and cancer pro-
gression has been discussed for centuries. The chronic 
inflammatory conditions that correlate with infection and 
irritation may prompt genomic lesions and tumor initiation.30 
Reports have found that breast cancer patients exhibit ele-
vated lipid peroxidation marker, MDA,31 and inflammatory 
mediator, NO.32 In this study, kefir water successfully 
reduced the levels of MDA and NO in kefir water–treated 
Figure 4. The results from cytokine (IL-10, IFN-γ, IL-1β, IL-2) enzyme-linked immunosorbent assay (ELISA) assay on blood serum 
from the untreated cancer group and kefir water–treated cancer group. Data are presented as means ± SD (n = 6 mice per group). 
Significant difference (*P < .05) from the untreated group was determined using the t-test.
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Figure 5. Flow cytometry dot plots and histograms of immune markers (CD3, CD4, and CD8) on splenocytes harvested from 
the normal group, untreated cancer group, and kefir water–treated cancer group. Data are presented as means ± SD. Significant 
difference (*P < .05) from the untreated group was determined using the t-test.
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mice. The decrease in NO was associated with significant 
downregulation of iNOS in the kefir water–treated group 
(Figure 7A). The overexpression of iNOS is highly corre-
lated with tumor progression and angiogenesis ability.33 
The activation of NF-κβ, which follows infectious agents or 
cytokines such as TNF-α, regulates the inflammatory 
response of iNOS and also ICAM-1, an adhesion molecule 
closely related to metastasis.34,35 Therefore, the reduction of 
these proinflammatory genes will help in providing a micro-
environment that disfavors tumor growth.
The suppression of IL-2 and IFN-γ, which were gener-
ated by T-helper 1, are common in the case of chronic infec-
tious diseases.35 The effects of kefir water in the regulation 
of IL-2 and IFN-γ cytokines were also analyzed, and the 
kefir water–treated group showed increments in both cyto-
kines. IL-2 is a product of activated CD4+ T cells and CD8+ 
T cells.36 Furthermore, IFN-γ is known to increase the pro-
duction of major histocompatibility complex and obstructs 
tumor angiogenesis.35 This antitumor immunity stimulation 
was validated by the in immunophenotyping assay, where 
notably increased numbers of immune markers (CD4+/
CD3+, CD8+/CD3+) were observed in the kefir water–
treated group (Figure 5). In fact, kefir has also been reported 
to exert immunomodulating effects, when IgA+ and IgG+ 
were increased in the healthy treatment group.37 Both CD4 
helper T cells and CD8 cytotoxic T cells are highly impor-
tant in immune response and producing antitumor response.38 
The inability of the immune system to eradicate tumors was 
mainly a result of the immunosuppressive environment pro-
duced by the developing tumor. The tumor suppressed both 
T cell populations in the untreated group as compared with 
the normal group and kefir water–treated group (Figure 5). 
However, this observation was dissimilar to that in a previ-
ous kefir study.17 IL-4 and IL-10 are some of the Th2 cyto-
kines that are formed in a COX-2 expressing environment, 
and these cytokines are able to obstruct the production of 
Th-1 cytokines by CD4+ T helper lymphocytes.35 A study by 
Sharma et al39 on the Lewis lung tumors in mice suggested 
that the overexpression of IL-10 decreased the cytolytic 
activity of CD8+. A similar outcome was observed in a 
study by Jarnicki et al40 in which a corresponding increase 
in IL-10 diminished cytotoxic T cell responses and IFN-γ 
secreting T cells during tumor growth. An increase of IL-10 
expression and reduction in the CD8+ population were 
observed in the untreated group when compared with the 
kefir water–treated group.
The role of kefir water as an antiangiogenic agent in 
breast cancer was further investigated through the expres-
sion of several angiogenesis-related cytokines, genes, and 
proteins. For tumor growth to obtain the capability to acti-
vate angiogenesis, it requires an angiogenic switch.41 The 
angiogenic factors of IL-1β that encourage tumor invasive-
ness were observed in various experimental models.42,43 In 
the cytokine and gene expression assay, kefir water signifi-
cantly reduced the level of IL-1β in the tumor environment. 
Furthermore, kefir water also inhibited the level of IL-10 
cytokine, which is associated with poor prognosis.44
Growth factors cause tumors to develop and migrate. 
Some important hematopoietic growth factors studied in 
this experiment included vascular endothelial growth factor 
(VEGF), granulocyte-colony stimulating factor (G-CSF), 
and granulocyte macrophage-colony stimulating factor 
(GM-CSF). The expression of VEGF is an essential media-
tor for angiogenesis, and it is abundant in many types of 
cancer malignancies, especially in breast cancer.45,46 In 
addition, the activation of VEGF promotes the growth of 
endothelial cells and migration.47 G-CSF was identified as a 
macrophage regulator to promote proliferation, differentia-
tion, and survival.48 However, G-CSF along with GM-CSF 
can also act as proto-oncogenes, in which they are highly 
expressed in various tumors49-51 and also frequently found 
in invasive breast cancer cells.52 They were also found in 
abundance in the cytokine profile of metastatic 4T1 
Figure 6. (A) NO levels in tumors from the untreated and 
kefir water–treated groups. (B) Malonaldehyde (MDA) levels 
in tumors from the untreated group and kefir water–treated 
group. Data are presented as means ± SD. Significant difference 
(*P < .05) from the untreated group was determined using the 
t-test.
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tumors.53 The levels of VEGF, G-CSF, and GM-CSF were 
significantly downregulated in the kefir water–treated 
group proteome profiler as compared with the untreated 
group. In addition, kefir water reduced the expression level 
of eotaxin, which is a member of the CC chemokine family. 
Chemokines are involved in the angiogenesis process by 
stimulating proangiogenic immune cells or by activating G 
protein–coupled chemokine receptors, which affect the tis-
sue microenvironments.54
The disruption and deregulation of the extracellular 
matrix (ECM) often leads to cancer progression. In chronic 
diseases, the disruption and remodeling of ECM by matrix 
metalloproteinases (MMPs) will affect several attributes of 
the cancer cells, such as the invasiveness, and metastatic 
and angiogenesis potentials.55 MMP-9 is one of the impor-
tant players in the MMP family, promoting vascular events 
in tumors as well as stimulating VEGF.56 Tissue inhibitor of 
metalloproteinases (TIMPs) is an endogenous inhibitor that 
regulates the activities of MMP-9 in cancer cells.55 Keeping 
the level of MMP-9 and TIMPs in check is important in 
reducing angiogenesis in cancer cells. MMP-9 expression is 
commonly abundant in metastatic breast cancer cells.57 On 
the other hand, the increase in TIMPs such as TIMP-1 and 
TIMP-2 in the tumor microenvironment can kill cancer 
cells and reduce cancer proliferation.58 The balance between 
the downregulation of MMP-9 and upregulation of TIMP-1 
Figure 7. (A) Relative mRNA expression levels of ICAM, iNOS, MMP-9, IL-1β, NF-κB, G-CSF, GM-CSF, IL-4, and TNF-α. Each value 
represents the mean ± SD. Significant difference (*P < .05) from the untreated group was determined using the t-test. The experiment 
was done in triplicate. (B) The angiogenesis-related proteome array test was performed to evaluate the level of change of selected 
proteins. Data are presented as means ± SD. Significant difference (*P < .05) from the untreated group was determined using the 
t-test.
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and TIMP-2 were demonstrated in the kefir water–treated 
group, and this equilibrium was important in reducing can-
cer. This antiangiogenic potential of kefir water was vali-
dated with lung clonogenic and bone marrow smearing 
assays, where significantly fewer 4T1 cells were observed 
in the lung of the kefir water–treated mice, and no abnormal 
cells were found in the bone marrow of the kefir water–
treated mice. The immunomodulation potential of kefir 
water, which aids in inhibiting tumor cell growth has also 
been observed in other studies using murine models of 
breast cancers and sarcomas, whereby tumor growth was 
inhibited by enhancing the local immune system response 
and by increasing the total IgA level.5,59
The constituents of kefir that could have antitumor prop-
erties are mostly the polysaccharide and exopolysaccha-
rides isolated from kefir grains as well as components 
released during fermentation, as suggested by previous 
studies.11,16,60 Interestingly, we have detected gallic acid as 
the major phenolic acid in the kefir water (result not shown). 
The antitumor effects and cytotoxicity of gallic acid extracts 
on many cell lines have been extensively observed over the 
years.61 Thus, further studies on kefir water should include 
the effects of antitumor and immunomodulation activity of 
the gallic acid detected in kefir water.
Conclusion
In this study, kefir water was able to reduce 4T1 cell prolif-
eration, migration, and invasion in vitro. An ex vivo angio-
genesis assay was also performed, and kefir water showed 
positive results in inhibiting angiogenesis. In addition, 
kefir water exhibited antimetastatic and antiangiogenesis 
effects in 4T1 cell–challenged mice in vivo through reduc-
ing 4T1 cell mitosis, promoting apoptosis, modulating 
immune systems, inhibiting inflammation in the tumor 
microenvironment, and regulating angiogenesis-related 
proteins and genes. Thus, these findings are crucial in pro-
moting kefir water as part of the diet intake for cancer 
patients.
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